| Literature DB >> 29682450 |
Meshal Alyousef1, Rabia Aldoghaither2.
Abstract
Spinal epidural abscess (SEA) is an extremely rare and disastrous musculoskeletal complication of spondylodiscitis and sacroilitis secondary to brucellosis infection. Few case reports and retrospective studies have been published reporting patients with epidural abscesses mainly lumbar, and thoracic while cervical abscess are rare. Management of spinal epidural abscess due to Brucella species is not standard and remains controversial. To the best of our knowledge this is the first case of brucellar cervical epidural abscess reported in Saudi Arabia. In this paper, we review the literature and report a case of a 67-year-old Saudi gentleman, who presented with fever and back pain. Further evaluation revealed cervical epidural abscess and a positive serology for brucellosis. Following 6 months of antibiotic therapy alone against brucellosis, he showed significant clinical and radiological improvement. Spinal epidural abscess caused by brucellosis is a rare condition, difficult to diagnose, and can be complicated by disastrous neurological or vascular complication if left untreated. Brucellosis must be considered as a possible cause of spinal epidural abscess in patients from endemic area. Hence, early detection and initiation of appropriate medical treatment alone is crucial in preventing permanent neurological complication, and possibly avoid surgical intervention.Entities:
Keywords: Brucellosis; Epidural abscess; Medical; Spinal; Treatment
Year: 2018 PMID: 29682450 PMCID: PMC5909065 DOI: 10.1016/j.idcr.2018.04.003
Source DB: PubMed Journal: IDCases ISSN: 2214-2509
Fig. 1Sagittal cervical T1 weighted magnetic resonance imaging (MRI) showing epidural collection along the posterior aspect of C5–C7 vertebral bodies causing moderate spinal stenosis.
Fig. 2Control Sagittal cervical T1 weighted magnetic resonance imaging (MRI) showing significant improvement of the epidural collection.
Baseline demographics, risk factors, involved location, antibiotic regimen and duration of patients.
| Case number | Author | Published year | Country | Number of cases | Age/Sex | Risk factors | Co-morbidities | location | Antibody titer | Isolate | Spinal cord compression | Antibiotics regimen | Duration | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | perez-calvo et a l. [ | 1994 | Spain | 1 | 62/male | N/A | Free | L5–S1 | 1/5120 | B.melitensis | Yes | Doxycycline Rifampicin Streptomycin | 6 weeks | Recovery |
| 2 | perez-calvo et al. [ | 1994 | Spain | 1 | 34/male | N/A | Free | L5–S1 | 1/2560 | B.melitensis | Yes | Doxycycline Rifampicin Cotrimoxazole | 6 months | Recovery |
| 3 | Solera et al. [ | 1999 | Spain | 2 | N/A | N/A | N/A | C5–C6 | N/A | N/A | No | N/A | N/A | Recovery |
| C6–C7 | ||||||||||||||
| 4 | Pina et al. [ | 2001 | Spain | 1 | 53/female | Farmer | Free | C5–C6 | 1/80 | N/A | No | Doxycycline Rifampicin streptomycin | 4 months | Recovery |
| 5 | Malavolta et al. [ | 2002 | Italy | 1 | 45/female | N/A | Free | L4–L5 | 1/640 | N/A | Yes | Doxycycline Rifampicin | 8 weeks | Recovery |
| 6 | Ugarriza et al. [ | 2005 | Spain | 5 | 47/female | Unpasterurized milk ingestion | Free | C5–T1 | 160/1< | B.melitensis | Yes | Doxycycline Rifampicin | 8 weeks | Recovery |
| 56/female | T6–T7 | No | ||||||||||||
| 31/male | L4–S2 | No | ||||||||||||
| 55/male | L4–L5 | No | ||||||||||||
| 34/male | L1–L2 | no | ||||||||||||
| 7 | Guzey FK et al. [ | 2007 | Turkey | 1 | 61/male | N/A | Free | C2–C3 | 1/640 | Brucella abotrus | Yes | Doxycycline Rifampicin Streptomycin | 24 weeks | Recovery |
| 8 | Nas et al. [ | 2007 | Turkey | 1 | 35/female | raw goat’s milk cheese | Free | C1–C2 | 1/320 | N/A | Yes | Doxycycline Rifampicin Cotrimoxazole | 6 months | Recovery |
| 9 | Sengul et al. [ | 2008 | Turkey | 1 | 37/male | Farmer | Free | C7–T1 | 1/160 | N/A | Yes | Doxycycline Rifampicin Streptomycin | 3 months | Recovery |
| 10 | Kim et al. [ | 2008 | Korea | 1 | 56/male | Farmer and cow breeding | Free | L4–L5 | 1/320 | N/A | No | Doxycycline Rifampicin Gentamycin | 7 weeks | Recovery |
| 11 | Chelli bouaziz et al. [ | 2010 | Tunisia | 1 | 66/male | N/A | Free | L2–L3 | 1/240 | N/A | Yes | Rifampicin Rovamycin | 8 weeks | Recovery |
| 12 | Christos et al. [ | 2012 | Greece | 1 | 70/female | Farmer and sheep breeding | Hypertension | C4–C5 | −ve | N/A | Yes | Doxycycline Rifampicin Streptomycin | 4 months | Recovery |
| 13 | Ahmet et al. [ | 2013 | Turkey | 1 | 33/female | Unpasteurized milk ingestion | Free | L3–L4 | 1/160 | N/A | Yes | Doxycycline Rifampicin | 16 weeks | Recovery |
| 14 | Our patients | 2017 | Saudi Arabia | 1 | 67/male | Unpasteurized milk ingestion | DM | C5–C7 | 1/2560 | N/A | No | Doxycycline Rifampicin Gentamicin | 6 months | Recovery |
Streptomycin was given for 21 days.
Gentamicin was given 10–15 days.